Cadre Diabetes

CADRE is a non-profit organization committed to reducing the burden of diabetes by providing health care professionals with scientific information and educational initiatives designed to translate research into effective clinical practice.

Diabetes Education from CADRE

CADRE's Current Diabetes Practice - The current issue of the CADRE newsletter contains information on obesity treatments, including a review of pharmacotherapy for weight loss and the status of FDA approval for new weight loss drugs, clinical strategies for lifestyle counseling, and treatment options for overweight pediatric patients. You can also read archived issues.
Cases in Success - Web-based, interactive case studies about various treatment strategies for type 2 diabetes. Although accreditation for these case studies has expired, you can still obtain valuable information and complete the cases for your own non-accredited education.
CADRE's I DO initiative to Impact Diabetes Outcomes is a multi-year curriculum covering the spectrum of diabetes management, including:
   - Cardiovascular risk management
   - Diabetic kidney disease
   - Diabetic peripheral neuropathy
   - Hypoglycemia
   - Insulin therapy
   - New antidiabetic therapies
   - Special populations
   - Weight management
Our goal for I DO is to provide healthcare practitioners with the tools to translate cutting-edge research into improved clinical management and improved outcomes for individual patients. As I DO programs are developed, links will be posted on this page.
   »II DO seek the most up-to-date information
     about diabetes treatment strategies

Funding for CADRE

CADRE's educational activities are funded from many sources, including Amylin Pharmaceuticals, Amylin-Lilly, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly & Company, GlaxoSmithKline, Johnson & Johnson, LifeScan, Merck & Co., Novartis, Novo Nordisk, Nutrition 21, Pfizer, and sanofi-aventis.

Resources

Dr Lois Jovanovic's Story
Dr. Jovanovic talks of her grandmother—one of the first children with diabetes to use insulin
The Updated CADRE A1C Position Statement
CADRE recommends the lowest A1C possible without unacceptable hypoglycemia
Diabetes Treatment Options Tables
Download concise,
up-to-date information on diabetes treatment options
Oral Drug Therapy and Insulin Therapy
Updated treatment information for The CADRE Handbook of Diabetes Management







forgot password?

MONTHLY MESSAGE:

CADRE's Cases in Success

©2011 CADRE - Council for the Advancement of Diabetes Research and Education.
All information, materials, functions, and other content ("Content") contained on the CADRE site is our copyrighted property or the copyrighted property of our licensors or licensees. Except as we specifically agree in writing, no Content from the CADRE site may be used, reproduced, transmitted, distributed or otherwise exploited in any way other than as part of the CADRE site, except that where a CADRE site is configured to enable the download of particular Content, you may download one copy of such Content to a single computer for your personal, noncommercial home use only, provided that you (a) keep intact all copyright and other proprietary notices, (b) make no modifications to the Content, and (c) do not use the Content in a manner that suggests an association with any of our products, services or brands.